Fatma Nur Karatas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fatma Nur Karatas has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Volkan Korten
Marmara University, School of Medicine
2 shared publications - Buket Erturk Sengel
Department of Infectious Diseases and Clinical Microbiology, University of Marmara, İstanbul, Turkey
1 shared publication - Caglayan Keklikkiran
Department of Gastroenterology, School of Medicine, Recep Tayyip Erdoğan University, Rize, Türkiye
1 shared publication D Y Sahin
Adana Numune Training and Research Hospital, Adana, Turkey
1 shared publication- Elif Tukenmez Tigen
Marmara University
1 shared publication - Hasan Koca
Department of Cardiology, University of Health Sciences - Adana Health Practice and Research Center, Adana, Turkey
1 shared publication
Latest Publications
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 23 (2) , 121-132
Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1
Background: Modern Anti-retroviral Therapy (ART) prevents disease progression in people living with HIV. Due to the increasing age of people living with HIV, the detection and management of comorbidities has become more important. Objective: In this study, we aimed to detect the prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and associated risk factors among people living with HIV followed up in our center. Methods: This single-center, cross-sectional study included people living with HIV, on ART for ≥1 year and virologic suppression for ≥6 months, presenting for routine follow-up between October 1, 2021, and April 1, 2022. Participants with a concurrent etiology for hepatic steatosis were excluded. Transient elastography (TE) was performed. NAFLD was defined as a controlled attenuation parameter (CAP) ≥248 dB/m; significant fibrosis (≥F2) was defined as liver stiffness measurement ≥7.1 kPa. Results: A total of 102 people living with HIV (84% men; median age, 39 years [IQR 33-52.5]) were enrolled. The treatment regimen of all participants included a nucleos(t)ide reverse transcriptase inhibitor and an integrase strand transfer inhibitor. TE analysis indicated NAFLD in 28 (27.5%) and fibrosis in 9 (8.8%; 6 with NAFLD) participants. In multivariable analysis, type two diabetes (OR:5.7 [95% CI 1.4-22.2], p=0.013), larger waist circumference (OR:1.1 [95% CI 1.03-1.16], p=0.007), higher alanine aminotransferase (OR:1.05 [95% CI 1.01-1.09], p=0.018), and higher thyroid stimulating hormone (OR:3.1 [95% CI 1.4-6.8], p=0.005] were independently associated with NAFLD. Conclusion: We observed a significant prevalence of NAFLD among people living with HIV followed up in our center. The high prevalence of NAFLD in our sample mirrors that of the general population, likely due to rising rates of metabolic dysfunction. Our findings highlight the importance of timely screening and implementation of management strategies for NAFLD in this population.
- 1 March 2025
- Published by Bentham Science Publishers Ltd. in Current HIV Research
- Vol. 23 (2) , 121-132
Prevalence and Associated Factors of Non-Alcoholic Fatty Liver Disease in People Living with HIV-1
Background: Modern Anti-retroviral Therapy (ART) prevents disease progression in people living with HIV. Due to the increasing age of people living with HIV, the detection and management of comorbidities has become more important. Objective: In this study, we aimed to detect the prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and associated risk factors among people living with HIV followed up in our center. Methods: This single-center, cross-sectional study included people living with HIV, on ART for ≥1 year and virologic suppression for ≥6 months, presenting for routine follow-up between October 1, 2021, and April 1, 2022. Participants with a concurrent etiology for hepatic steatosis were excluded. Transient elastography (TE) was performed. NAFLD was defined as a controlled attenuation parameter (CAP) ≥248 dB/m; significant fibrosis (≥F2) was defined as liver stiffness measurement ≥7.1 kPa. Results: A total of 102 people living with HIV (84% men; median age, 39 years [IQR 33-52.5]) were enrolled. The treatment regimen of all participants included a nucleos(t)ide reverse transcriptase inhibitor and an integrase strand transfer inhibitor. TE analysis indicated NAFLD in 28 (27.5%) and fibrosis in 9 (8.8%; 6 with NAFLD) participants. In multivariable analysis, type two diabetes (OR:5.7 [95% CI 1.4-22.2], p=0.013), larger waist circumference (OR:1.1 [95% CI 1.03-1.16], p=0.007), higher alanine aminotransferase (OR:1.05 [95% CI 1.01-1.09], p=0.018), and higher thyroid stimulating hormone (OR:3.1 [95% CI 1.4-6.8], p=0.005] were independently associated with NAFLD. Conclusion: We observed a significant prevalence of NAFLD among people living with HIV followed up in our center. The high prevalence of NAFLD in our sample mirrors that of the general population, likely due to rising rates of metabolic dysfunction. Our findings highlight the importance of timely screening and implementation of management strategies for NAFLD in this population.
- Open Access
- 30 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 3 (3) , 164-176
A Rare Case of Otitis Media-Associated Polymicrobial Anaerobic Meningitis and Brain Abscess
A cute otitis media (AOM) primarily occurs in childhood. While the incidence of AOM is 45% to 60% in children under the age of five, this rate was 3.1 to 3.5 in adults aged 15-24. The most common causative bacterial pathogens are (...)
- 30 December 2021
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 3 (3) , 164-176
Open AccessA Rare Case of Otitis Media-Associated Polymicrobial Anaerobic Meningitis and Brain Abscess
A cute otitis media (AOM) primarily occurs in childhood. While the incidence of AOM is 45% to 60% in children under the age of five, this rate was 3.1 to 3.5 in adults aged 15-24. The most common causative bacterial pathogens are (...)
- Open Access
- 1 March 2018
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 20 (suppl_1) , i136
P777S-R difference in V1-V2 is a novel criterion for differentiating the left from right ventricular outflow tract arrhythmias
Aim: The correct estimation of the VA origin as RVOT or LVOT results in reduced ablation duration reduced radiation exposure and decreased number of vascular access. In our study, we aimed to detect the predictive value of S-R difference in V1-V2 for differentiating the left from right ventricular outflow tract arrhythmias.
- 1 March 2018
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 20 (suppl_1) , i136
Open AccessP777S-R difference in V1-V2 is a novel criterion for differentiating the left from right ventricular outflow tract arrhythmias
Aim: The correct estimation of the VA origin as RVOT or LVOT results in reduced ablation duration reduced radiation exposure and decreased number of vascular access. In our study, we aimed to detect the predictive value of S-R difference in V1-V2 for differentiating the left from right ventricular outflow tract arrhythmias.